As shown in Fig. 4b, highly expressed CARM1 is linked to poor prognosis of overall survival (OS) for cancers such as ACC (P = 0.0021), BLCA (P = 0.0066), KIRP (kidney renal papillary cell carcinoma, P = 0.033), LGG (Brain lower Grade Glioma, P = 0.00014), MESO (Mesothelioma, P = 0.00046), SKCM (skin cutaneous melanoma, P = 0.0026). Here, CARM1 is linked to bladder transitional cell carcinoma.